Terms: = Bone cancer AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769
107 results:
1. Identification of potential biomarkers for aging diagnosis of mesenchymal stem cells derived from the aged donors.
Hao M; Jiang H; Zhao Y; Li C; Jiang J
Stem Cell Res Ther; 2024 Mar; 15(1):87. PubMed ID: 38520027
[TBL] [Abstract] [Full Text] [Related]
2. Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.
Trottier AM; Feurstein S; Godley LA
Best Pract Res Clin Haematol; 2024 Mar; 37(1):101537. PubMed ID: 38490765
[TBL] [Abstract] [Full Text] [Related]
3. Pathogenic gata2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program.
Katsumura KR; Liu P; Kim JA; Mehta C; Bresnick EH
Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2317147121. PubMed ID: 38422019
[TBL] [Abstract] [Full Text] [Related]
4. Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.
Arai H; Matsui H; Chi S; Utsu Y; Masuda S; Aotsuka N; Minami Y
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203823
[TBL] [Abstract] [Full Text] [Related]
5. Linking gata2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia.
Robbins DJ; Pavletich TS; Patil AT; Pahopos D; Lasarev M; Polaki US; Gahvari ZJ; Bresnick EH; Matson DR
Blood Adv; 2024 Jan; 8(1):80-92. PubMed ID: 38029365
[TBL] [Abstract] [Full Text] [Related]
6. Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Cuccuini W; Collonge-Rame MA; Auger N; Douet-Guilbert N; Coster L; Lafage-Pochitaloff M
Curr Res Transl Med; 2023; 71(4):103423. PubMed ID: 38016422
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic work-up of hematological malignancies with underlying germline predisposition disorders (GPD).
Kanagal-Shamanna R; Schafernak KT; Calvo KR
Semin Diagn Pathol; 2023 Nov; 40(6):443-456. PubMed ID: 37977953
[TBL] [Abstract] [Full Text] [Related]
8. The Molecular and Genetic Mechanisms of Inherited bone Marrow Failure Syndromes: The Role of Inflammatory Cytokines in Their Pathogenesis.
Kawashima N; Bezzerri V; Corey SJ
Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627314
[TBL] [Abstract] [Full Text] [Related]
9. Genome-wide transcription factor-binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs.
Subramanian S; Thoms JAI; Huang Y; Cornejo-Páramo P; Koch FC; Jacquelin S; Shen S; Song E; Joshi S; Brownlee C; Woll PS; Chacon-Fajardo D; Beck D; Curtis DJ; Yehson K; Antonenas V; O'Brien T; Trickett A; Powell JA; Lewis ID; Pitson SM; Gandhi MK; Lane SW; Vafaee F; Wong ES; Göttgens B; Alinejad-Rokny H; Wong JWH; Pimanda JE
Blood; 2023 Oct; 142(17):1448-1462. PubMed ID: 37595278
[TBL] [Abstract] [Full Text] [Related]
10. A novel gata2 distal enhancer mutation results in MonoMAC syndrome in 2 second cousins.
West RR; Bauer TR; Tuschong LM; Embree LJ; Calvo KR; Tillo D; Davis J; Holland SM; Hickstein DD
Blood Adv; 2023 Oct; 7(20):6351-6363. PubMed ID: 37595058
[TBL] [Abstract] [Full Text] [Related]
11. Inherited bone marrow failure syndromes and germline predisposition to myeloid neoplasia: A practical approach for the pathologist.
Li J; Bledsoe JR
Semin Diagn Pathol; 2023 Nov; 40(6):429-442. PubMed ID: 37507252
[TBL] [Abstract] [Full Text] [Related]
12. The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A Canadian sarcoma research and Clinical Collaboration (CanSaRCC) study.
Tzelnick S; Soroka HP; Tasnim N; Gilbert RW; Irish JC; Goldstein DP; Brown D; Gullane P; Chepeha DB; Yao CMKL; Sahovaler A; Witterick IJ; Monteiro E; Davies J; Huang SH; O'Sullivan B; Hahn E; Hosni A; Razak AA; Gupta AA; de Almeida JR
Oral Oncol; 2023 Oct; 145():106495. PubMed ID: 37478572
[TBL] [Abstract] [Full Text] [Related]
13. How I diagnose myeloid neoplasms with germline predisposition.
Patel N; Calvo KR
Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
[TBL] [Abstract] [Full Text] [Related]
14. Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.
Molteni E; Bono E; Gallì A; Elena C; Ferrari J; Fiorelli N; Pozzi S; Ferretti VV; Sarchi M; Rizzo E; Camilotto V; Boveri E; Cazzola M; Malcovati L
Blood; 2023 Aug; 142(7):643-657. PubMed ID: 37216690
[TBL] [Abstract] [Full Text] [Related]
15. Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring gata2 mutation.
Sato Y; Fukatsu M; Suzuki T; Sasajima T; Gunji N; Yoshida S; Asano N; Fukuchi K; Mori H; Takano M; Hayashi K; Takahashi H; Shirado-Harada K; Kimura S; Koyama D; Migita K; Ikezoe T
Int J Hematol; 2023 Nov; 118(5):642-646. PubMed ID: 37084069
[TBL] [Abstract] [Full Text] [Related]
16. Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study.
Baranwal A; Chhetri R; Yeung D; Clark M; Shah S; Litzow MR; Hogan WJ; Mangaonkar A; Alkhateeb HB; Singhal D; Cibich A; Bardy P; Kok CH; Hiwase DK; Shah MV
Bone Marrow Transplant; 2023 Jul; 58(7):769-776. PubMed ID: 37012415
[TBL] [Abstract] [Full Text] [Related]
17. Pathogenic human variant that dislocates gata2 zinc fingers disrupts hematopoietic gene expression and signaling networks.
Jung MM; Shen S; Botten GA; Olender T; Katsumura KR; Johnson KD; Soukup AA; Liu P; Zhang Q; Jensvold ZD; Lewis PW; Beagrie RA; Low JK; Yang L; Mackay JP; Godley LA; Brand M; Xu J; Keles S; Bresnick EH
J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36809258
[TBL] [Abstract] [Full Text] [Related]
18. Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT).
Clark A; Thomas S; Hamblin A; Talley P; Kulasekararaj A; Grinfeld J; Speight B; Snape K; McVeigh TP; Snowden JA
Br J Haematol; 2023 Apr; 201(1):35-44. PubMed ID: 36786081
[TBL] [Abstract] [Full Text] [Related]
19. Somatic genetic alterations predict hematological progression in gata2 deficiency.
Largeaud L; Collin M; Monselet N; Vergez F; Fregona V; Larcher L; Hirsch P; Duployez N; Bidet A; Luquet I; Bustamante J; Dufrechou S; Prade N; Nolla M; Hamelle C; Tavitian S; Habib C; Meynier M; Bellanne-Chantelot C; Donadieu J; De Fontbrune FS; Fieschi C; Ferster A; Delhommeau F; Delabesse E; Pasquet M
Haematologica; 2023 Jun; 108(6):1515-1529. PubMed ID: 36727400
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the bone Marrow Pathology Group.
Cantu MD; Kanagal-Shamanna R; Wang SA; Kadia T; Bueso-Ramos CE; Patel SS; Geyer JT; Tam W; Madanat Y; Li P; George TI; Nichols MM; Rogers HJ; Liu YC; Aggarwal N; Kurzer JH; Maracaja DLV; Hsi ED; Zaiem F; Babu D; Foucar K; Laczko D; Bagg A; Orazi A; Arber DA; Hasserjian RP; Weinberg OK
JCO Precis Oncol; 2023 Jan; 7():e2200400. PubMed ID: 36689697
[TBL] [Abstract] [Full Text] [Related]
[Next]
